BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 6860573)

  • 1. Photochemotherapy (PUVA) in the treatment of urticaria pigmentosa.
    Vella Briffa D; Eady RA; James MP; Gatti S; Bleehen SS
    Br J Dermatol; 1983 Jul; 109(1):67-75. PubMed ID: 6860573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of cutaneous mast cells to PUVA in patients with urticaria pigmentosa: histomorphometric, ultrastructural, and biochemical investigations.
    Kolde G; Frosch PJ; Czarnetzki BM
    J Invest Dermatol; 1984 Sep; 83(3):175-8. PubMed ID: 6470520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased urinary histamine metabolite after successful PUVA treatment of urticaria pigmentosa.
    Granerus G; Roupe G; Swanbeck G
    J Invest Dermatol; 1981 Jan; 76(1):1-3. PubMed ID: 7462662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dermal mastocytes, histaminaemia, and oral photochemotherapy (author's transl)].
    Ortonne JP; Forestier JY; Souteyrand P; Thivolet J
    Ann Dermatol Venereol; 1980 Mar; 107(3):129-34. PubMed ID: 7258977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phototherapy of urticaria pigmentosa: clinical response and changes of cutaneous reactivity, histamine and chemotactic leukotrienes.
    Czarnetzki BM; Rosenbach T; Kolde G; Frosch PJ
    Arch Dermatol Res; 1985; 277(2):105-13. PubMed ID: 2580493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short- and long-term effectiveness of oral and bath PUVA therapy in urticaria pigmentosa and systemic mastocytosis.
    Godt O; Proksch E; Streit V; Christophers E
    Dermatology; 1997; 195(1):35-9. PubMed ID: 9267734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basophil/mast cell precursors in mast cell proliferative disorders.
    Denburg JA; Telizyn S; Ahlstedt S; Olafsson JH; Roupe G; Bienenstock J
    Clin Invest Med; 1986; 9(1):21-5. PubMed ID: 3955917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photochemotherapy of dominant, diffuse, cutaneous mastocytosis.
    Smith ML; Orton PW; Chu H; Weston WL
    Pediatr Dermatol; 1990 Dec; 7(4):251-5. PubMed ID: 2080117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult-onset urticaria pigmentosa and systemic mast cell disease.
    Travis WD; Li CY; Su WP
    Am J Clin Pathol; 1985 Dec; 84(6):710-4. PubMed ID: 4072966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spectrum of mastocytosis.
    Tharp MD
    Am J Med Sci; 1985 Mar; 289(3):119-32. PubMed ID: 2579553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histamine release from skin mast cells and basophils in patients with urticaria pigmentosa.
    Nolte H; Søderberg U; Thestrup Pedersen K; Schiøtz PO
    Acta Derm Venereol; 1990; 70(2):154-6. PubMed ID: 1690493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal mucosal mast cells: enumeration in urticaria pigmentosa and systemic mastocytosis.
    Ferguson J; Thompson RP; Greaves MW
    Br J Dermatol; 1988 Nov; 119(5):573-8. PubMed ID: 3207611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mastocytosis and the mast cell.
    DiBacco RS; DeLeo VA
    J Am Acad Dermatol; 1982 Dec; 7(6):709-22. PubMed ID: 7174910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous and systemic mastocytosis in adults. A clinical, histopathological and immunological evaluation in relation to histamine metabolism.
    Olafsson JH
    Acta Derm Venereol Suppl (Stockh); 1985; 115():1-43. PubMed ID: 3901645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urticaria pigmentosa treated with oral disodium cromoglycate.
    Lindskov R; Lange Wantzin G; Knudsen L; Søondergaard I
    Dermatologica; 1984; 169(1):49-52. PubMed ID: 6432596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on histamine metabolism in mastocytosis.
    Granerus G; Olafsson JH; Roupe G
    J Invest Dermatol; 1983 May; 80(5):410-6. PubMed ID: 6841997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD25 expression on cutaneous mast cells from adult patients presenting with urticaria pigmentosa is predictive of systemic mastocytosis.
    Hollmann TJ; Brenn T; Hornick JL
    Am J Surg Pathol; 2008 Jan; 32(1):139-45. PubMed ID: 18162781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sudden death in the presence of systemic mastocytosis and urticaria pigmentosa].
    Wehner F; Wehner HD; Fritz P; Benz D; Schulz MM
    Arch Kriminol; 2008; 222(5-6):187-94. PubMed ID: 19216369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The skin in mastocytosis.
    Soter NA
    J Invest Dermatol; 1991 Mar; 96(3):32S-38S; discussion 38S-39S. PubMed ID: 1672136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bone marrow in urticaria pigmentosa and systemic mastocytosis. Cell composition and mast cell density in relation to urinary excretion of tele-methylimidazoleacetic acid.
    Ridell B; Olafsson JH; Roupe G; Swolin B; Granerus G; Rödjer S; Enerbäck L
    Arch Dermatol; 1986 Apr; 122(4):422-7. PubMed ID: 3954410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.